Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology

por Commo, F., Ferté, C., Soria, J. C., Friend, S. H., André, F., Guinney, J.
Publicado no Ann Oncol (2015)

Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis

por Soria, J C, Morat, L, Commo, F, Dabit, D, Perie, S, Sabatier, L, Fouret, P
Publicado em 2001

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

por Lecharpentier, A, Vielh, P, Perez-Moreno, P, Planchard, D, Soria, J C, Farace, F
Publicado em 2011

Detection of circulating carcinoma cells by telomerase activity

por Gauthier, L R, Granotier, C, Soria, J-C, Faivre, S, Boige, V, Raymond, E, Boussin, F D
Publicado em 2001

BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with...

por Loriot, Y, Mordant, P, Dorvault, N, De la motte Rouge, T, Bourhis, J, Soria, J-C, Deutsch, E
Publicado em 2010

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients

por Ady, N, Morat, L, Fizazi, K, Soria, J-C, Mathieu, M-C, Prapotnich, D, Sabatier, L, Chauveinc, L
Publicado em 2004

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours

por Lantuejoul, S, Soria, J C, Moro-Sibilot, D, Morat, L, Veyrenc, S, Lorimier, P, Brichon, P Y, Sabatier, L, Brambilla, C, Brambilla, E
Publicado em 2004

A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours

por Boven, E, Massard, C, Armand, J P, Tillier, C, Hartog, V, Brega, N M, Countouriotis, A M, Ruiz-Garcia, A, Soria, J C
Publicado em 2010

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized t...

por Reiman, T., Lai, R., Veillard, A. S., Paris, E., Soria, J. C., Rosell, R., Taron, M., Graziano, S., Kratzke, R., Seymour, L., Shepherd, F. A., Pignon, J. P., Sève, P.
Publicado em 2012

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

por Pailler, E., Auger, N., Lindsay, C. R., Vielh, P., Islas-Morris-Hernandez, A., Borget, I., Ngo-Camus, M., Planchard, D., Soria, J.-C., Besse, B., Farace, F.
Publicado no Ann Oncol (2015)

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours

por Vicent, S, López-Picazo, J M, Toledo, G, Lozano, M D, Torre, W, Garcia-Corchón, C, Quero, C, Soria, J-C, Martín-Algarra, S, Manzano, R G, Montuenga, L M
Publicado em 2004

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapi...

por Macaulay, V. M., Middleton, M. R., Protheroe, A. S., Tolcher, A., Dieras, V., Sessa, C., Bahleda, R., Blay, J.-Y., LoRusso, P., Mery-Mignard, D., Soria, J.-C.
Publicado em 2013

Radiosensitization by a novel Bcl-2 and Bcl-X(L) inhibitor S44563 in small-cell lung cancer

por Loriot, Y, Mordant, P, Dugue, D, Geneste, O, Gombos, A, Opolon, P, Guegan, J, Perfettini, J-L, Pierre, A, Berthier, L K, Kroemer, G, Soria, J C, Depil, S, Deutsch, E
Publicado no Cell Death Dis (2014)

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma

por Even, C., Lassen, U., Merchan, J., Le Tourneau, C., Soria, J-C, Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A., Massard, Christophe
Publicado no Invest New Drugs (2019)

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

por Farace, F, Massard, C, Vimond, N, Drusch, F, Jacques, N, Billiot, F, Laplanche, A, Chauchereau, A, Lacroix, L, Planchard, D, Le Moulec, S, André, F, Fizazi, K, Soria, J C, Vielh, P
Publicado em 2011

PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer

por Tsao, M.-S., Le Teuff, G., Shepherd, F. A., Landais, C., Hainaut, P., Filipits, M., Pirker, R., Le Chevalier, T., Graziano, S., Kratze, R., Soria, J.-C., Pignon, J.-P., Seymour, L., Brambilla, E.
Publicado no Ann Oncol (2017)

1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center

por Hauchecorne, M., Baldini, C., Foulon, S., Bayle, A., Gachot, B., Pommeret, F., Willekens, C., Griscelli, F., Netzer, F., Balleyguier, C., Ammari, S., André, F., Scotté, F., Besse, B., Soria, J-C., Barlesi, F., Albiges, L.
Publicado no Ann Oncol (2020)

Severe COVID-19 in patients with hematological cancers presenting with viremia

por Michot, J.M., Hueso, T., Ibrahimi, N., Pommeret, F., Willekens, C., Colomba, E., Francis, S., Bayle, A., Cournède, P.H., Merad, M., Foulon, S., Albiges, L., Gachot, B., Barlesi, F., Soria, J.C., Ribrag, V., Griscelli, F.
Publicado no Ann Oncol (2021)

Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial

por Rodon, J., Soria, J. C., Berger, R., Batist, G., Tsimberidou, A., Bresson, C., Lee, J. J., Rubin, E., Onn, A., Schilsky, R. L., Miller, W. H., Eggermont, A. M., Mendelsohn, J., Lazar, V., Kurzrock, R.
Publicado no Ann Oncol (2015)

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin

por Ploquin, A, Olmos, D, Lacombe, D, A'Hern, R, Duhamel, A, Twelves, C, Marsoni, S, Morales-Barrera, R, Soria, J-C, Verweij, J, Voest, E E, Schöffski, P, Schellens, J H, Kramar, A, Kristeleit, R S, Arkenau, H-T, Kaye, S B, Penel, N
Publicado em 2012